Myomo, Inc. (MYO) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Win.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
45/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinMYO / S&P 53.85% / 15.20% |
LoseMYO / S&P 6.14% / 15.00% |
WinMYO / S&P 54.55% / 50.40% |
| 2026-Q11/3 |
LoseMYO / S&P -25.71% / -4.33% |
LoseMYO / S&P 6.68% / 11.30% |
WinMYO / S&P 157.14% / 27.70% |
| 2025-Q42/3 |
LoseMYO / S&P 2.02% / 2.65% |
WinMYO / S&P 25.73% / 9.00% |
WinMYO / S&P 131.25% / 13.40% |
| 2025-Q32/3 |
LoseMYO / S&P -58.70% / 8.12% |
WinMYO / S&P 64.99% / 4.61% |
WinMYO / S&P 21.74% / 13.45% |
| 2025-Q21/3 |
LoseMYO / S&P -55.09% / 10.94% |
WinMYO / S&P 93.07% / 4.83% |
LoseMYO / S&P -15.38% / 10.63% |
| 2025-Q11/3 |
LoseMYO / S&P -25.31% / -4.27% |
WinMYO / S&P 97.60% / 4.98% |
LoseMYO / S&P -48.15% / 10.57% |
| 2024-Q42/3 |
WinMYO / S&P 60.60% / 2.41% |
WinMYO / S&P 69.17% / 5.25% |
LoseMYO / S&P -42.86% / 6.15% |
| 2024-Q32/3 |
WinMYO / S&P 24.92% / 5.89% |
WinMYO / S&P 36.23% / 5.89% |
LoseMYO / S&P -53.06% / 6.11% |
| 2024-Q21/3 |
LoseMYO / S&P -1.83% / 4.28% |
WinMYO / S&P 21.22% / 5.38% |
LoseMYO / S&P -68.67% / 5.12% |
| 2024-Q11/3 |
LoseMYO / S&P -34.73% / 10.56% |
WinMYO / S&P 29.17% / 5.71% |
LoseMYO / S&P -77.69% / 5.59% |
| 2023-Q42/3 |
WinMYO / S&P 351.35% / 11.69% |
WinMYO / S&P 23.70% / 6.81% |
LoseMYO / S&P -81.46% / 7.78% |
| 2023-Q32/3 |
WinMYO / S&P 114.29% / -3.27% |
WinMYO / S&P 19.18% / 7.52% |
LoseMYO / S&P -71.84% / -5.03% |
| 2023-Q20/3 |
LoseMYO / S&P -30.93% / 8.74% |
LoseMYO / S&P 9.11% / 9.50% |
LoseMYO / S&P -51.18% / -8.57% |
| 2023-Q11/3 |
WinMYO / S&P 46.77% / 7.50% |
LoseMYO / S&P -1.65% / 10.77% |
LoseMYO / S&P -30.46% / -15.69% |
| 2022-Q41/3 |
LoseMYO / S&P -68.46% / 7.56% |
WinMYO / S&P 12.26% / 11.88% |
LoseMYO / S&P MYO unavailable / -17.99% |
| 2022-Q32/3 |
WinMYO / S&P -3.57% / -4.88% |
WinMYO / S&P 14.18% / 13.47% |
LoseMYO / S&P MYO unavailable / -1.41% |
| 2022-Q21/3 |
LoseMYO / S&P -55.91% / -16.10% |
WinMYO / S&P 43.05% / 13.71% |
LoseMYO / S&P MYO unavailable / 11.04% |
| 2022-Q11/3 |
LoseMYO / S&P -44.34% / -4.60% |
WinMYO / S&P 72.67% / 15.97% |
LoseMYO / S&P MYO unavailable / 42.23% |
| 2021-Q41/3 |
LoseMYO / S&P -42.43% / 11.03% |
WinMYO / S&P 82.72% / 15.00% |
LoseMYO / S&P MYO unavailable / 96.40% |
| 2021-Q32/3 |
WinMYO / S&P 10.09% / 0.58% |
WinMYO / S&P 156.20% / 10.77% |
LoseMYO / S&P MYO unavailable / 69.42% |
| 2021-Q21/3 |
LoseMYO / S&P -15.63% / 8.55% |
WinMYO / S&P 179.35% / 6.58% |
LoseMYO / S&P MYO unavailable / 51.81% |
| 2021-Q12/3 |
WinMYO / S&P 90.19% / 6.17% |
WinMYO / S&P 121.92% / -1.06% |
LoseMYO / S&P MYO unavailable / 7.39% |
| 2020-Q42/3 |
WinMYO / S&P 50.22% / 12.15% |
WinMYO / S&P 97.60% / -3.72% |
LoseMYO / S&P MYO unavailable / -33.42% |
| 2020-Q32/3 |
WinMYO / S&P 21.41% / 8.93% |
WinMYO / S&P 65.72% / -2.04% |
LoseMYO / S&P MYO unavailable / -27.10% |
| 2020-Q21/3 |
LoseMYO / S&P 3.36% / 20.54% |
WinMYO / S&P 24.47% / -0.46% |
LoseMYO / S&P MYO unavailable / -27.11% |
| 2020-Q11/3 |
LoseMYO / S&P -60.47% / -19.60% |
WinMYO / S&P 35.62% / 3.47% |
LoseMYO / S&P MYO unavailable / -14.75% |
| 2019-Q41/3 |
LoseMYO / S&P -51.06% / 9.07% |
WinMYO / S&P 57.02% / 5.36% |
LoseMYO / S&P MYO unavailable / 2.99% |
| 2019-Q31/3 |
LoseMYO / S&P -12.14% / 1.70% |
WinMYO / S&P 52.55% / 5.02% |
LoseMYO / S&P MYO unavailable / 0.21% |
| 2019-Q21/3 |
LoseMYO / S&P -41.67% / 4.30% |
WinMYO / S&P 61.95% / 6.64% |
LoseMYO / S&P MYO unavailable / 8.65% |
| 2019-Q11/3 |
LoseMYO / S&P -16.67% / 13.65% |
WinMYO / S&P 78.82% / 8.12% |
LoseMYO / S&P MYO unavailable / 14.29% |
| 2018-Q41/3 |
LoseMYO / S&P -25.77% / -13.52% |
WinMYO / S&P 56.79% / 9.05% |
LoseMYO / S&P MYO unavailable / 18.23% |
| 2018-Q31/3 |
LoseMYO / S&P -34.46% / 7.71% |
WinMYO / S&P 44.01% / 10.21% |
LoseMYO / S&P MYO unavailable / 19.06% |
| 2018-Q21/3 |
LoseMYO / S&P -0.34% / 3.43% |
WinMYO / S&P 71.53% / 9.03% |
LoseMYO / S&P MYO unavailable / 14.46% |
| 2018-Q11/3 |
LoseMYO / S&P -20.80% / -0.76% |
WinMYO / S&P 50.18% / 7.68% |
LoseMYO / S&P MYO unavailable / 12.46% |
| 2017-Q40/3 |
LoseMYO / S&P -37.50% / 6.64% |
LoseMYO / S&P MYO unavailable / 7.03% |
LoseMYO / S&P MYO unavailable / 13.82% |
| 2017-Q30/3 |
LoseMYO / S&P -44.70% / 4.48% |
LoseMYO / S&P MYO unavailable / 5.68% |
LoseMYO / S&P MYO unavailable / 17.57% |
| 2017-Q20/3 |
LoseMYO / S&P MYO unavailable / 3.09% |
LoseMYO / S&P MYO unavailable / 4.83% |
LoseMYO / S&P MYO unavailable / 17.74% |
| 2017-Q10/3 |
LoseMYO / S&P MYO unavailable / 6.07% |
LoseMYO / S&P MYO unavailable / 3.67% |
LoseMYO / S&P MYO unavailable / 13.32% |
| 2016-Q40/3 |
LoseMYO / S&P MYO unavailable / 3.82% |
LoseMYO / S&P MYO unavailable / 2.09% |
LoseMYO / S&P MYO unavailable / 7.05% |
| 2016-Q30/3 |
LoseMYO / S&P MYO unavailable / 3.85% |
LoseMYO / S&P MYO unavailable / 0.20% |
LoseMYO / S&P MYO unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | MYO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 58.10% | 20.78% |
| Annualized return | 58.10% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | MYO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -84.96% | 83.14% |
| Annualized return | -31.54% | 12.86% |
10Y · 2017-06-12 to 2026-08-27
| Metric | MYO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.25% | 319.30% |
| Annualized return | -38.71% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B |